Subsequently, abundant intestinal MYC targets ceramide synthase 4 (Cers4) to stimulate ceramide synthesis and simultaneously decrease glucagon-like peptide 1 (GLP-1) secretion, facilitating obesity [135]. The gene discussed is MYC; the disease is Obesity.